YBX1 and acute myeloid leukemia: Analysing the proteomics data of MV4‐11 sEVs and BM‐MSCs treated with MV4‐11 sEVs together showed that YBX1, which plays a key role in AML development and maintenance is significantly upregulated in both the samples.